Comparison of urea recirculation and thermodilution for monitoring of vascular access in patients undergoing hemodialysis

J Vasc Access. 2018 May;19(3):283-290. doi: 10.1177/1129729817747536. Epub 2018 Mar 7.

Abstract

Introduction It is important to monitor vascular access in patients with stage 5 chronic kidney disease receiving hemodialysis. Access recirculation can help to detect a need for intervention.

Objectives: To compare urea recirculation with recirculation by thermodilution using blood temperature monitoring to predict a need for intervention of vascular access over a 6-month period.

Methods: We analyzed urea recirculation and blood temperature monitoring simultaneously in 61 patients undergoing hemodialysis. During the 6-month follow-up, we recorded all cases of angioplasty or surgery (thrombectomy or reanastomosis). In line with previous studies, we considered a value to be positive when urea recirculation was >10% and blood temperature monitoring >15%. Receiver operating characteristic curves were constructed.

Results: Mean urea recirculation was 9.5% ± 6.6% and mean blood temperature monitoring 12.9% ± 4.3% (p = 0.001). Urea recirculation >10% had a sensitivity of 80% and specificity of 78%. Blood temperature monitoring >15% had a sensitivity of 33% and specificity of 85%. During follow-up, 25% of patients developed need for intervention of vascular access. We found an association between vascular access dysfunction and urea recirculation. The Kaplan-Meier analysis confirmed an association between urea recirculation and risk of vascular access dysfunction (log rank = 17.2; p = 0.001). We were unable to confirm this association with blood temperature monitoring (log rank = 0.879; p = 0.656).

Conclusion: Urea recirculation is better predictor of vascular access dysfunction than thermodilution.

Keywords: Blood temperature monitoring; hemodialysis; recirculation; thermodilution; urea; vascular access.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Area Under Curve
  • Arteriovenous Shunt, Surgical* / adverse effects
  • Biomarkers / blood
  • Blood Vessel Prosthesis Implantation* / adverse effects
  • Female
  • Graft Occlusion, Vascular / blood
  • Graft Occlusion, Vascular / diagnosis*
  • Graft Occlusion, Vascular / etiology
  • Graft Occlusion, Vascular / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • ROC Curve
  • Renal Dialysis* / adverse effects
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / therapy*
  • Reproducibility of Results
  • Temperature*
  • Thermodilution*
  • Time Factors
  • Treatment Outcome
  • Urea / blood*
  • Vascular Patency*

Substances

  • Biomarkers
  • Urea